Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cefcapene pivoxil methanesulfonate

A technology for cefcapine axetil and mesylate, which is applied to medical preparations containing active ingredients, antibacterial drugs, organic chemistry, etc. The effect of efficient recycling

Inactive Publication Date: 2008-01-23
SHIONOGI & CO LTD
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But all do not record the mesylate of cefcapene pivoxil in these documents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cefcapene pivoxil methanesulfonate
  • Cefcapene pivoxil methanesulfonate
  • Cefcapene pivoxil methanesulfonate

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0030] (1) Preparation of mesylate

[0031] The mesylate salts of the invention are preferably crystalline. The crystal may be a solvate, but is preferably an ansolvate. In the case of a solvate, examples of the solvent include water, alcohols (eg, methanol, ethanol), ketones (eg, methyl isobutyl ketone), and the like.

[0032] The crystal preferably shows the main peaks shown below by powder X-ray diffraction.

[0033] 2θ=17.93, 18.61, 19.63, 20.17, 20.93, 22.39, 24.79, 25.71 (unit: degree)

[0034] The method for producing the methanesulfonate is not particularly limited, but it is preferably produced from the corresponding hydrochloride. For example, methanesulfonic acid can be added to a solution containing cefcapene pivoxil hydrochloride in a solvent, preferably an organic solvent, to precipitate methanesulfonate or a solvate thereof, preferably crystals thereof.

[0035] Pure methanesulfonic acid may be used, or commercially available 70% methanesulfonic acid for ind...

Embodiment 1

[0054] Embodiment 1 (reclaims mesylate from mother washing liquor)

[0055] According to the method described in the preparation example 3 of the patent No. 2960790 bulletin (corresponding publication number: JP-P-4-295485), the 7-position amino protection body (7β-[(Z)-2-(2- tert-butoxycarbonylaminothiazol-4-yl)-2-butenoyl]amino-3-carbamoyloxymethyl-3-cephem-4-carboxylic acid pivaloyloxymethyl ester) 1039g Raw materials, under the condition that solvents and reagents are increased in proportion according to the amount of raw materials used, the same deprotection reaction is carried out to crystallize cefcapene axetil hydrochloride, filter, and collect crystals by filtration. The obtained crystals were washed successively with methyl isobutyl ketone and dichloromethane.

[0056] The mother lotion obtained by mixing 6.9 L of the filtrate (mother liquor) separated in the above-mentioned filtration process and 3.1 L of the washing liquor (wash liquor) separated after washing wit...

Embodiment 2

[0064] Embodiment 2 (hydrochlorination of mesylate)

[0065] Slurry 20.0 g of cefcapene pivoxil mesylate obtained in Example 1 in 140 mL of dichloromethane was added with 140 mL of ethanol water whose concentration was previously adjusted to 60.5%, and stirred and mixed. 5.9 g of a 20% aqueous sodium hydroxide solution was added thereto to neutralize and dissolve, and then the aqueous layer was removed by extraction. Then, it was extracted twice with 60 mL of 2.5% aqueous sodium chloride solution for washing to obtain an extract. In addition, the aqueous layer obtained during the extraction was back-extracted with 60 mL of dichloromethane, and the obtained back-extracted dichloromethane layer was combined with the extract. The combined extracts were concentrated under reduced pressure, and dichloromethane was distilled off to obtain about 48 g of an ethanol solution of cefcapene pivoxil. Dilute the obtained solution with 60 mL of methyl isobutyl ketone, drop it into a mixtur...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A process for producing cefcapene pivoxil methanesulfonate and, with the use thereof as an intermediate, corresponding hydrochloride. There is provided methanesulfonate of the compound of the formula ().

Description

technical field [0001] The present invention relates to the mesylate salt of cefcapene pivoxil. In detail, the present invention relates to the method for preparing cefcapene pivoxil hydrochloride via the mesylate. Background technique [0002] Mode: [0003] [chemical 1] [0004] [0005] Represented compound (I) (common name: cefcapene pivoxil; chemical name: 7β-[(Z)-2-(2-aminothiazol-4-yl)-2-butenoyl (butenoyl)]amino-3 -carbamoyloxymethyl-3-cephem (cephem)-4-carboxylic acid pivaloyloxymethyl ester) is a cephalosporin (Sepham series) antibacterial agent (reference: Patent Document 1). An antibacterial agent Foromox Tablets (trade name, Sionogi) containing its monohydrochloride monohydrate (common name: cefcapene pivoxil hydrochloride, reference: Patent Document 2) as an active ingredient is commercially available. In Patent Document 1, trifluoroacetate was synthesized from the protected form of the 7-amino group of cefcapene proxetil via the free form (cefcapene pro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D501/34A61K31/546A61P31/04
CPCC07D501/00A61P31/04A61K31/546C07B2200/13C07D501/34
Inventor 上仲正朗井出丰若原繁西馆修
Owner SHIONOGI & CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com